Navigation Links
Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
Date:1/23/2009

ROCKVILLE, Md., Jan. 23 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Penny Heaton, V.P., and Chief Medical Officer, will be presenting at the Phacilitate Vaccine Forum Washington 2009 conference on January 26, 2009 at the Grand Hyatt in Washington D.C. Dr. Heaton is participating in the Focus Session 'What benefits are single-use technologies and other novel vaccine manufacturing solutions providing in practice' and will be speaking to the Case Study: Virus-Like Particle (VLP) based vaccines for pandemic and seasonal influenza. Slides from the presentation will be posted on the Novavax website at www.novavax.com.

There are several reasons for utilizing virus-like particle technology as a vaccine platform. Recombinant technology permits tailoring of vaccines to contain only those proteins that are immunologically important for protection and structurally important for optimizing expression and yields. In addition, preclinical and clinical data have shown that VLPs activate multiple arms of the immune system, inducing robust humoral and cell-mediated immunity, which permits vaccine development for a wide range of disease targets. Further, VLPs may be more cost effective to produce because vaccines against different disease targets may be manufactured utilizing the same process and facility. Dr. Heaton's presentation will discuss these advantages, with a specific focus on the potential immunologic and manufacturing benefits of Novavax's pandemic and seasonal influenza VLP vaccines.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to addre
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
2. Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008
3. Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference
4. Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
5. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
6. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
7. Novavax CEO to Present at BIO Investor Forum 2008
8. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
9. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
10. Novavax Announces Closing of $18 Million Registered Direct Offering
11. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Isagenix International, a leading global health and ... Silver, and three Bronze Stevie® Awards at the 2015 ... Chicago this month.The American Business Awards ... in the U.S. "Winning is a ... leaders, cultivating talent, creating a unified team, and crafting ...
(Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA ... transmission. CTI’ new Medical Joysticks have an impermeable molecular barrier protection against ... operator control device that will increase healthcare worker safety and reduce financial costs. ...
(Date:6/30/2015)... R-Japan Co.,Ltd. obtained the license of cell processing facility under ... Ministry of Health, Labour and Welfare Kinki Bureau of Health ... fact that R- Japan received the license ... Medical Devices Agency (PMDA) on May 18, 2015 two months ... manufacturing service to medical institutions. As of November 25, 2014, ...
Breaking Biology Technology:Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2
... providing marketing automation solutions, today introduced NuEdge Suite ... respond to the increasing complexity of consumer interactions: ... NuEdge Suite 3.0 features: , , A ... information, including customer accounts, teller/POS interfaces, Web sites, ...
... and COO, served as his companies representative on the ... of the Electronic Product Code (EPC) Technology Network, which ... database. Provia Software is a Michigan-based warehouse ... tagging (RFID). The company has been working with Gillette ...
... headquartered in Milwaukee, the world's largest print music publisher, ... technology company, announced today that will be bundling SmartMusic ... Elements 2000 for Band Book 1 and Essential Elements ... technology-based music practice system with over 20,000 fun accompaniments, ...
Cached Biology Technology:WTN Interview: John Pulling, Provia Software
Hitting the Wal-Mart RFID Deadline 2
WTN Interview: John Pulling, Provia Software
Hitting the Wal-Mart RFID Deadline 3
(Date:6/15/2015)... YORK , June 15, 2015 ... today from Telstra reveals the majority of US consumers using ... them via biometrics, such as fingerprint and voiceprint, instead of ... According to Telstra,s " Mobile Identity   - ... " report, with smartphones now the primary channel used ...
(Date:6/11/2015)... , June 11, 2015 Daon, a ... today that its IdentityX Mobile Authentication Platform v4.0 ... Online) Alliance is an industry consortium launched in ... for simpler, stronger authentication.  In order to receive ... a rigorous series of tests that measure compliance ...
(Date:6/9/2015)... Research and Markets  ( http://www.researchandmarkets.com/research/xsgs2s/gesture ) ... Recognition & Touchless Sensing Market by Technology (Touch-based ... Product (Biometric & Sanitary Equipment) & by Geography ... their offering. The total gesture recognition ... $ 23.55 Billion by 2020 at a high ...
Breaking Biology News(10 mins):One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2
... Geneva, Switzerland, 15 February, 2012The World Economic Forum,s Global ... list of "Important Technologies" that will change the world ... most likely to impact on the state of the ... a cross section of experts from science, businesses, and ...
... PITTSBURGH, Feb. 14, 2012 Neuro Kinetics, Inc. (NKI) ... diagnostic equipment used worldwide for neurophysiologic/ neurotologic testing, said ... of Health,s (NIH) Feedback Sessions in Washington D.C. on ... are an invitation only program funded by the NIH ...
... MELBOURNE, Australia -- Victoria will be home to ... supercomputer, the IBM Blue Gene/Q, which will be housed ... by the University of Melbourne, and is aimed at ... acquisition of the IBM supercomputer is the second stage ...
Cached Biology News:Important Emerging Technologies for the 21st Century 2Important Emerging Technologies for the 21st Century 3Neuro Kinetics Invited to Present at NIH Forum for Investors and Strategic Partners 2World's greenest supercomputer heads to Melbourne to boost health research 2
Adult Bovine Serum US Origin...
... 13(S)-HODE-d4 contains 4 deuterium atoms at the 9, ... for use as an internal standard for the ... 13(S)-HODE is produced by incubation of linoleic acid ... shown to inhibit the adhesion of tumor cells ...
...
...
Biology Products: